BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19499276)

  • 1. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
    Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
    Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma.
    Sergeant G; Ectors N; Fieuws S; Aerts R; Topal B
    Ann Surg Oncol; 2009 Nov; 16(11):3070-9. PubMed ID: 19649555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.
    Uehara H; Miyamoto M; Kato K; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Hase R; Takahashi R; Mega S; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer Res; 2004 May; 64(10):3533-7. PubMed ID: 15150108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
    Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
    Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
    Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
    Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
    Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
    Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CD74 on the prognosis of patients with resectable pancreatic cancer.
    Zhang JF; Hua R; Liu DJ; Liu W; Huo YM; Sun YW
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):81-6. PubMed ID: 24463084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
    Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
    Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome.
    Einama T; Kagata Y; Tsuda H; Morita D; Ogata S; Ueda S; Takigawa T; Kawarabayashi N; Fukatsu K; Sugiura Y; Matsubara O; Hatsuse K
    Pancreas; 2006 May; 32(4):376-81. PubMed ID: 16670630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
    Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
    Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.